CNO

CNO Financial Group, Inc. 2025 Annual Report (10-K) Summary

Business Context and Reporting Period

This summary covers the fiscal year ended December 31, 2025. CNO Financial Group, Inc. is a holding company for a group of insurance companies focusing on health insurance, annuities, and individual life insurance for middle-income pre-retiree and retired Americans. The company operates through three primary product lines (Annuity, Health, Life) and two sales divisions (Consumer and Worksite). In November 2025, management announced an intention to exit the fee services business within the Worksite Division to focus on core insurance operations.

Key Financial Metrics

Material Changes vs. Prior Period

• Net Income Decline: GAAP net income decreased 45% to $229.3 million from $420.8 million in 2024. This decline was driven primarily by non-operating items, including a $101.9 million goodwill and intangible asset impairment charge related to the Optavise, LLC business and a $64.0 million loss from changes in the fair value of embedded derivative liabilities and market risk benefits.
• Operating Performance: Net Operating Income (excluding non-operating items) increased 2% to $439.2 million. Insurance product margin grew to $1.07 billion, driven by growth in the Health segment (margin of $556.6 million) and Life segment (margin of $272.4 million), partially offset by a decline in Annuity margin to $238.6 million.
• Premium Growth: Total premium collections increased 4.9% to $4.59 billion. Fixed indexed annuity collections rose 12.8%, while Medicare supplement sales were strong in Q4, reflecting a shift in consumer preference away from Medicare Advantage.
• Divestiture: The company began exiting the fee services business within the Worksite Division in Q4 2025, resulting in a $17.3 million net loss related to divested business.

Guidance, Outlook, and Risks

• 2026 Outlook: Management expects operating earnings per diluted share in the range of $4.25 to $4.45. The expense ratio is expected to range from 18.8% to 19.2%. Free cash flow is projected between $200 million and $250 million.
• Strategic Initiatives: The company is executing "TechMod," a three-year technology modernization initiative expected to cost approximately $170 million, with costs largely expensed as incurred and excluded from operating earnings.
• Key Risks:
  • Interest Rate Risk: A return to low interest rates could compress spreads between investment income and credited rates. Conversely, rising rates could increase surrenders.
  • Regulatory Risk: The company faces extensive state and federal regulation regarding rate increases, capital requirements (RBC), and market conduct. Approval of rate increases is not guaranteed.
  • Investment Risk: The portfolio is subject to credit losses and fair value fluctuations. Structured securities comprise 30.9% of fixed maturity investments.
  • Reinsurance Risk: The company relies on third-party reinsurers; failure of a reinsurer to perform could negatively impact earnings.

Investor Verification Checklist

• Impairment Details: Verify the specific assumptions and valuation methodology used for the $101.9 million impairment charge related to Optavise, LLC.
• Actuarial Assumptions: Review the 2025 comprehensive annual actuarial review results, specifically the changes in surrender, mortality, and morbidity assumptions that impacted the $41.3 million favorable adjustment to insurance product margins.
• Dividend Capacity: Confirm the ability of U.S. insurance subsidiaries to pay dividends to the holding company, noting that several subsidiaries have negative earned surplus and require regulatory approval for distributions.
• Reinsurance Concentration: Assess the credit quality of the top seven reinsurers, which accounted for 97% of ceded life insurance inforce and 99% of reinsurance receivables.
• TechMod Costs: Monitor the actual spend and timeline of the TechMod initiative to ensure it remains within the projected $170 million budget and does not disrupt operations.